EUVIMEDEUVIMED entdecken
Crossref

[ 68 Ga]Ga-FAPI04 Outperforms [ 18 F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience

Serkan Kuyumcu iD, Emine Göknur Isik, Cömert Şen, Duygu Has-Şimsek, Bora Başaran, Zeynep Gözde Özkan, Fikret Büyükkaya, Yasemin Şanlı

Cancer Biotherapy and Radiopharmaceuticals · 2025

DOI: 10.1089/cbr.2024.0112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, 2025. Verfasst von Serkan Kuyumcu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Fluorodeoxyglucose F18, Lymphatic Metastasis, Squamous Cell Carcinoma of Head and Neck. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study assesses fibroblast activated protein inhibitor (FAPI) targeted PET/CT imaging against [18F]FDG PET/CT (FDG PET) for detecting nodal involvement in head and neck squamous cell carcinoma (HNSCC), intending to improve diagnostic precision for metastatic lymph nodes and lay the groundwork for future investigations.

Methods

Patients diagnosed with HNSCC were retrospectively enrolled. All patients underwent [68Ga]Ga-FAPI04 PET/CT (FAPI PET) and FDG PET within 6 d. Primary tumor, lymph nodes, and tracer uptake were visually and quantitatively compared. The metastatic lymph nodes were evaluated using patient-and lesion-based analyses, with biopsy or postoperative histopathological examination as the reference.

Results

The cohort includes 24 patients (17 men, 7 women; mean age 60 ± 11.8 years) who underwent FDG and FAPI PET for preoperative diagnostic workup or restaging due to known recurrence of HNSCC. Lesions included 24 primary tumors, 54 cervical lymph nodes, and 5 metastases. Primary tumors exhibited significant uptake on both PET modalities (median maximum standardized uptake value [SUVmax]: FDG 19.4 ± 11.6, FAPI 16.9 ± 4.6), with no statistically significant difference (p > 0.5). For lymph nodes, FAPI and FDG PET showed median SUVmax of 9.18 ± 6.77 and 9.67 ± 6.5, respectively. The patient-based analysis found FDG PET sensitivity at 88.2% and FAPI PET at 94.1%, with FAPI PET specificity significantly higher (85.7% vs. 42.8% for FDG PET). Lesion-based analysis revealed FAPI PET sensitivity and specificity at 84.2% and 93.7%, respectively, contrasting FDG PET's at 81.5% and 25%, respectively.

Conclusion

This study underscores the efficacy of FAPI PET in detecting primary tumors in HNSCC. Furthermore, FAPI PET shows improved specificity over FDG PET for metastatic lymph nodes advocating further investigations for integrating FAPI PET into HNSCC clinical protocols for its enhanced precision in detecting metastatic lymph nodes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyFluorodeoxyglucose F18Lymphatic MetastasisSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedGallium RadioisotopesRadiopharmaceuticalsLymph NodesQuinolines

Stichwörter der Autor:innen

FAPIPET/CT[68Ga]Ga-FAPIcancer-associated fibroblasthead and neck squamous cell carcinoma

Substanzen

Fluorodeoxyglucose F18Gallium Radioisotopes68Ga-FAPIRadiopharmaceuticalsQuinolines

Autor:innen und Institutionen

  • Faculty of Medicine, Department of Nuclear Medicine, Istanbul University, Istanbul, Turkey.
  • Faculty of Medicine, Department of Otolaryngology & Head and Neck Surgery, Istanbul University, Istanbul, Turkey.

ORCID-Profile: Serkan Kuyumcu

Zitieren

APA

Kuyumcu, S., Isik, E. G., Şen, C., Has-Şimsek, D., Başaran, B., Özkan, Z. G., Büyükkaya, F., & Şanlı, Y. (2025). [ 68 Ga]Ga-FAPI04 Outperforms [ 18 F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0112

Vancouver

Kuyumcu S, Isik EG, Şen C, Has-Şimsek D, Başaran B, Özkan ZG, et al. [ 68 Ga]Ga-FAPI04 Outperforms [ 18 F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience. Cancer Biotherapy and Radiopharmaceuticals. 2025. doi:10.1089/cbr.2024.0112

BibTeX
@article{Kuyumcu2025,
  author = {Kuyumcu, Serkan and Isik, Emine Göknur and Şen, Cömert and Has-Şimsek, Duygu and Başaran, Bora and Özkan, Zeynep Gözde and Büyükkaya, Fikret and Şanlı, Yasemin},
  title = {[ 68 Ga]Ga-FAPI04 Outperforms [ 18 F]FDG PET/CT for Detecting Nodal Metastasis of Head and Neck Squamous Cell Carcinoma: A Single-Center Experience},
  journal = {Cancer Biotherapy and Radiopharmaceuticals},
  year = {2025},
  doi = {10.1089/cbr.2024.0112}
}
Kostenlos starten →